Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A series of SynLeptin peptides, particularly, SynLeptin-2 shows remarkable anti-obesity activities which were verified in animal experiments using mice and rabbits. More
MRI contast medium More
Use of substituted or modified C60 fullerenes for the prevention or treatment of thrombosis, peripheral arterial occlusion, and catheter obstruction. More
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
Biodegradable microbead or microparticle useful for the sustained localized delivery of biologically active proteins or other molecules of pharmaceutical interest More
MRI contast medium More
Methods and compositions for making and using functionalized sugars More
Intravenously administered nanoparticles selectively cross the blood-brain barrier of brain tumors and accumulate within brain tumor cells but not normal brain cells More
CSIC has developed a magnetic nanoparticle which contains at least an active ingredient, which can be used for the treatment of cancer. It can be injected intravenously and targeted to the region of interest using an external magnetic field. More
Collagen-based biodegradable matrices for localized drug delivery More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 124 pages - $1,740
Jul 2011 - 147 pages - $3,835
Jan 2011 - 231 pages - $3,835
May 2011 - 25 pages - $250
Nov 2010 - 260 pages - $600
Feb 2012 - 672 pages - $1,040
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Jul 2010 - 98 pages - $750
Your selection
Browse By
- Industry sector
- Ampoule
- Cartridge
- Implant
- Injection vial
- Intramuscular
- Intravenous
- Needle-less
- Pen
- Pre-filled syringe
- Safety needle
- Subcutaneous
- Sustained release
- Unit dose
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us